Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Hellwig K, Ellmann S, Eckstein M, Wiesmueller M, Rutzner S, Semrau S, Frey B, Gaipl US, Gostian AO, Hartmann A, Iro H, Fietkau R, Uder M, Hecht M, Bäuerle T. Hellwig K, et al. Among authors: gostian ao. Front Oncol. 2021 Oct 21;11:734872. doi: 10.3389/fonc.2021.734872. eCollection 2021. Front Oncol. 2021. PMID: 34745957 Free PMC article.
Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin.
Sievert M, Goncalves M, Tamse R, Mueller SK, Koch M, Gostian AO, Iro H, Scherl C. Sievert M, et al. Among authors: gostian ao. Eur Arch Otorhinolaryngol. 2021 May;278(5):1567-1575. doi: 10.1007/s00405-020-06219-w. Epub 2020 Jul 24. Eur Arch Otorhinolaryngol. 2021. PMID: 32710177 Free PMC article.
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.
Hecht M, Gostian AO, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann MG, Klautke G, Laban S, Brunner T, Hinke A, Becker I, Frey B, Semrau S, Geppert CI, Hartmann A, Balermpas P, Budach W, Gaipl US, Iro H, Fietkau R. Hecht M, et al. Among authors: gostian ao. J Immunother Cancer. 2020 Oct;8(2):e001378. doi: 10.1136/jitc-2020-001378. J Immunother Cancer. 2020. PMID: 33023982 Free PMC article.
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy.
Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Frey B, Gaipl US, Zhou JG, Fietkau R, Hecht M. Schweizer C, et al. Among authors: gostian ao. Eur J Cancer. 2020 Nov;140:55-62. doi: 10.1016/j.ejca.2020.09.001. Epub 2020 Oct 9. Eur J Cancer. 2020. PMID: 33045663 Clinical Trial.
Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer.
Mueller SK, Mantsopoulos K, Semrau S, Agaimy A, Eckstein M, Traxdorf M, Gostian AO, Goncalves M, Sievert M, Haderlein M, Grundtner P, Hecht M, Koch M, Fietkau R, Iro H, Scherl C. Mueller SK, et al. Among authors: gostian ao. Acta Otolaryngol. 2021 Feb;141(2):187-192. doi: 10.1080/00016489.2020.1831697. Epub 2020 Oct 28. Acta Otolaryngol. 2021. PMID: 33108949
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors.
Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Zhou JG, Gaipl US, Fietkau R, Hecht M. Schubert P, et al. Among authors: gostian ao. Front Oncol. 2020 Oct 29;10:576643. doi: 10.3389/fonc.2020.576643. eCollection 2020. Front Oncol. 2020. PMID: 33251140 Free PMC article.
114 results